Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richard

Showing results (741-750 of 781) with videos related to

Pageof 79
Sort By:
Journal of the Royal Society of Medicine|November 3, 2023
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Utkarsh Agrawal, Mark Joy, et al.
Lancet (London, England)|March 4, 2018
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trialRichard J McManus, Jonathan Mant, Marloes Franssen, et al.
The Lancet Regional Health. Europe|January 1, 2024
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesStuart Bedston, Fatima Almaghrabi, Lynsey Patterson, et al.
The Lancet. Respiratory Medicine|June 10, 2022
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trialHugh Montgomery, F D Richard Hobbs, Francisco Padilla, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Parasitology|June 2, 2001
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasisJ Horton, C Witt, E A Ottesen, et al.
The Journal of Infection|August 29, 2020
Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel networkSimon de Lusignan, Mark Joy, Jason Oke, et al.
BMJ Open|October 1, 2025
Understanding structured medication reviews delivered by clinical pharmacists in primary care in England: a national cross-sectional surveyAdaku J Agwunobi, Anna E Seeley, Katherine L Tucker, et al.
European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.
Pageof 79

Showing results (741-750 of 781) with videos related to

Sort By:
Pageof 79
Journal of the Royal Society of Medicine|November 3, 2023
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Utkarsh Agrawal, Mark Joy, et al.
Lancet (London, England)|March 4, 2018
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trialRichard J McManus, Jonathan Mant, Marloes Franssen, et al.
The Lancet Regional Health. Europe|January 1, 2024
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesStuart Bedston, Fatima Almaghrabi, Lynsey Patterson, et al.
The Lancet. Respiratory Medicine|June 10, 2022
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trialHugh Montgomery, F D Richard Hobbs, Francisco Padilla, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Parasitology|June 2, 2001
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasisJ Horton, C Witt, E A Ottesen, et al.
The Journal of Infection|August 29, 2020
Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel networkSimon de Lusignan, Mark Joy, Jason Oke, et al.
BMJ Open|October 1, 2025
Understanding structured medication reviews delivered by clinical pharmacists in primary care in England: a national cross-sectional surveyAdaku J Agwunobi, Anna E Seeley, Katherine L Tucker, et al.
European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.
Pageof 79